Users Online: 133 | Home Print this page Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2012  |  Volume : 2  |  Issue : 3  |  Page : 99-105

A comprehensive study on regulatory requirements for development and filing of generic drugs globally


1 Drug Regulatory Affairs, Jubilant Life Sciences Ltd.; School of Pharmacy, Lloyd Institute of Management and Technology, Mahamaya Technical University, Greater Noida, India
2 School of Pharmacy, Lloyd Institute of Management and Technology, Mahamaya Technical University, Greater Noida, India
3 Drug Regulatory Affairs, Jubilant Life Sciences Ltd., Noida, India
4 University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Orissa, India

Correspondence Address:
Shweta Handoo
Drug Regulatory Affairs, Jubilant Life Sciences Ltd., Noida, India, and Department of Pharmaceutics, Lloyd Institute of Management and Technology, Mahamaya Technical University, Greater Noida
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2230-973X.104392

Rights and Permissions

The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be established before commencement of developmental work in order to avoid major surprises after submission of the application. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of all medicines in circulation in their country. It not only includes the process of regulating and monitoring the drugs but also the process of manufacturing, distribution, and promotion of it. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5377    
    Printed208    
    Emailed3    
    PDF Downloaded1587    
    Comments [Add]    
    Cited by others 4    

Recommend this journal